Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

NCT07531433 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: ATH434

Sponsor

Alterity Therapeutics